Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Where are we in the Robotics Revolution?

June 3, 2016

For years, Intuitive Surgical appeared to be the only company capable of cracking the code for medical robotics. But with companies like Medtronic, Stryker, Johnson & Johnson, Google, and others creating their own efforts the sector appears to be stabilizing. Is there room for early-stage entrepreneurs and VC investors in this capital-intensive sector?

Paul LaViolette

Managing Partner & COO

SV Life Sciences Advisers, LLC

Paul joined SV Life Sciences Advisers in 2009 and is focused on medical devices investments and brings over 33 years of global medical technology management experience. Paul was most recently Chief Operating Officer at Boston Scientific Corporation (BSC), an $8 billion medical device leader. During his 15 years at BSC, he served as Chief Operating Officer, Group President Cardiovascular, President, Cardiology, Group President, Endosurgery and President, International as the company grew revenues over 20 times. Paul integrated two dozen acquisitions and led extensive product development, operations and worldwide commercial organizations. He previously held marketing and general management positions at CR Bard, and various marketing roles at Kendall (Covidien). Paul serves as Vice Chairman of the Innovation Advisory Board for the Partners Health System and is Chairman-elect for the Medical Device Manufacturers Association. Paul received his BA in Psychology from Fairfield University and his MBA from Boston College. Current Board Seats: CardioFocus *, CardioKinetix, Cibiem, CSA Medical Direct Flow Medical * Soffio, TransEnterix *, ValenTX *, Ximedica * External Board Seats: Axon Therapies, Corvia *